Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense News Headlines of the Week – August 24, 2014

by Global Biodefense Staff
August 24, 2014
Global Biodefense News - MRSA

Global Biodefense News - MRSAGlobal fear of Ebola outbreak stokes a frenzy of new R&D | Air Force Secretary doubles down on nuclear mission | Analysis of chemicals relevant to the Chemical Weapons Convention | Marburg drug shows promise | Harnessing the power of convalescents for severe viral infections | Ebola puts focus on drugs made in tobacco plants | Why are so many women dying from Ebola? | Assessing FDA’s final guidance on companion diagnostics | 4th MEB trains for disaster on the homefront | Chikungunya vaccine clears Phase 1 | Treatment in U.S. rare chance to study Ebola | Seals infected early Americans with tuberculosis | Ebola crisis: Ivory Coast closes land borders | Plants and their growing role in the pharmaceutical industry | Confronting biological plagues like Ebola, smallpox, and anthrax | WHO: Ebola outbreak underestimated | Containing the international spread of Ebola | Large trial finds high-dose flu shot beneficial for seniors| Those who serve Ebola victims soldier on

See what we’re reading this week at Global Biodefense on plant-based vaccines, chemicals relevant to the Chemical Weapons Convention, Chikungunya vaccine and more…

Global fear of Ebola outbreak stokes a frenzy of new R&D (Fierce Biotech)

Air Force Secretary doubles down on nuclear mission (Defense One)

Marburg drug shows promise (The Scientist)

Analysis of chemicals relevant to the Chemical Weapons Convention (Springer Link)

Harnessing the power of convalescents for severe viral infections (UPMC CBN)

Ebola puts focus on drugs made in tobacco plants (Seattle Times)

Why are so many women dying from Ebola? (Foreign Policy)

Assessing FDA’s final guidance on companion diagnostics (MDT)

4th MEB trains for disaster on the homefront (DVIDS)

Chikungunya vaccine clears Phase 1 (The Scientist)

Treatment in U.S. rare chance to study Ebola (NY Times)

Seals infected early Americans with tuberculosis (Science)

Ebola crisis: Ivory Coast closes land borders (BBC News)

Plants and their growing role in the pharmaceutical industry (Pandora Report)

Confronting biological plagues like Ebola, smallpox, and anthrax (GEN)

WHO: Ebola outbreak underestimated (The Scientist)

Containing the international spread of Ebola (The Conversation)

Large trial finds high-dose flu shot beneficial for seniors (CIDRAP)

Those who serve Ebola victims soldier on (NY Times)

Tags: ChikungunyaEbolaMarburgVaccines

Related Posts

News Scan

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023
News Scan

Biodefense Headlines – 12 March 2023

March 12, 2023
Biodefense Headlines – 24 January 2023
News Scan

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023
News Scan

Biodefense Headlines – 17 January 2023

January 17, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC